|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
THIS PAGE IS UNDER CONSTRUCTION...10/16/06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
SundaySaturdayAvonex & Rebif(interferon beta-1a) Information: What is the most important information I should know about interferon beta-1a?
Contact your doctor immediately or seek emergency medical attention if you begin feeling depressed or anxious or if you have thoughts of suicide.
ThursdayOverview of MS: U.S. Pharmacist
This teaching module reviews the epidemiology, etiology, pathophysiology and clinical presentation of multiple sclerosis, disease-modifying drugs used to treat MS, symptomatic problems associated with MS and therapies for their management, and the role of pharmacists in care for patients with MS. Goal:To describe the epidemiology, etiology, pathophysiology, and clinical presentation of multiple sclerosis (MS) and discuss the various products used to treat acute exacerbations, slow the progression of the disease, and minimize symptomatic problems.
MORE: U.S. Pharmacist |